
Our medical experts are ready to answer your questions and guide you through your treatment options.
Understanding the PGT-A/PGT-M (Genetic Testing of Embryos) success rate is crucial for individuals pursuing fertility treatments in New Delhi. This diagnostic tool significantly impacts the journey towards a successful pregnancy, influencing decisions and expectations. The ultimate success relies on various factors, including the specific testing method, the underlying cause of infertility, and individual patient profiles. New Delhi has established itself as a prominent destination for advanced fertility care and data-reviewed outcomes.
Evaluating PGT-A/PGT-M outcomes in New Delhi involves reviewing aggregated clinical data from various leading fertility centers. Success rates are carefully assessed and compared against established benchmarks to ensure transparency and accuracy. It is important to note that reported outcomes can vary based on the specific laboratory protocols, patient demographics, and the definition of 'success' being considered. These evaluations contribute to a clearer understanding of treatment efficacy in the region.
For PGT-A/PGT-M (Genetic Testing of Embryos), 'success' encompasses several critical milestones rather than a single event. Initially, it refers to the successful biopsy of embryos and the accurate identification of euploid (chromosomally normal) or unaffected embryos. The broader definition extends to the successful implantation of such an embryo, leading to a clinical pregnancy, and ultimately, a live birth. Short-term success involves viable embryo selection, while long-term success is a healthy baby.
Success rates for PGT-A/PGT-M (Genetic Testing of Embryos) vary depending on the specific testing approach and various patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| PGT-A (Preimplantation Genetic Testing for Aneuploidy) | Screening embryos for chromosomal abnormalities in IVF cycles, especially for advanced maternal age or recurrent implantation failure. | 50%–70% | Live birth rate per euploid embryo transfer, reflecting the chance of a healthy pregnancy after transfer. |
| PGT-M (Preimplantation Genetic Testing for Monogenic Disease) | Identifying embryos free from specific inherited genetic conditions (e.g., cystic fibrosis, Huntington's disease) in couples who are carriers. | 45%–65% | Live birth rate per unaffected embryo transfer, indicating successful prevention of passing on a known genetic disorder. |
The success and survival rates associated with PGT-A/PGT-M (Genetic Testing of Embryos) are significantly influenced by maternal age, a trend consistently observed globally and within New Delhi's clinics. Older maternal age is generally linked to a higher incidence of aneuploidy in embryos. Consequently, the chance of identifying a euploid embryo suitable for transfer decreases with advancing age, directly impacting the overall live birth rate. These outcome trends align with internationally observed clinical practices and research findings.
| Age Group | Primary Consideration | Euploid Embryo Rate Range (%) | Live Birth Rate per Transfer Range (%) |
|---|---|---|---|
| Under 35 years | Generally higher egg quality, lower aneuploidy risk. | 55%–75% | 45%–60% |
| 35–37 years | Moderate decline in egg quality, increasing aneuploidy risk. | 40%–60% | 35%–50% |
| 38–40 years | Significant increase in aneuploidy, further decline in egg quality. | 25%–45% | 25%–40% |
| Over 40 years | High aneuploidy rates, fewer euploid embryos expected. | 10%–25% | 10%–25% |
Success rates for PGT-A/PGT-M (Genetic Testing of Embryos) in New Delhi are often comparable with international standards. This holds true when leading clinics in the city adhere to similar stringent protocols, utilize advanced laboratory technology, and apply appropriate patient selection criteria. The PGT-A/PGT-M (Genetic Testing of Embryos) survival rate in New Delhi mirrors global trends for similar demographic profiles.
| Region/Country | Live Birth Rate per Euploid Embryo Transfer Range (%) |
|---|---|
| New Delhi (India) | 40%–55% |
| United States | 45%–60% |
| United Kingdom | 40%–55% |
| Australia | 40%–58% |
| Spain | 42%–57% |
| Canada | 40%–55% |
| Czech Republic | 38%–52% |
Disclaimer: These rates are indicative averages, not a guarantee of individual outcomes. Actual results vary based on specific patient conditions and clinical approach.
Understanding the realistic PGT-A/PGT-M (Genetic Testing of Embryos) success rate in New Delhi empowers patients. This knowledge helps in making confident, data-driven decisions during their fertility journey, ensuring clarity and transparency.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.